PMID- 31955812 OWN - NLM STAT- MEDLINE DCOM- 20200428 LR - 20200428 IS - 1097-6744 (Electronic) IS - 0002-8703 (Linking) VI - 221 DP - 2020 Mar TI - Myocardial fibrosis and the effect of primary prophylactic defibrillator implantation in patients with non-ischemic systolic heart failure-DANISH-MRI. PG - 165-176 LID - S0002-8703(19)30351-5 [pii] LID - 10.1016/j.ahj.2019.10.020 [doi] AB - AIMS: Patients with non-ischemic systolic heart failure have an increased risk of sudden cardiac death (SCD). Myocardial fibrosis, detected as late gadolinium enhancement (LGE) with cardiac magnetic resonance (CMR), has been shown to predict all-cause mortality. We hypothesized that LGE can identify patients with non-ischemic heart failure who will benefit from ICD implantation. METHODS AND RESULTS: In this prospective observational sub-study of the Danish Study to Assess the Efficacy of ICDs in Patients with Nonischemic Systolic Heart Failure on Mortality (DANISH), 252 patients underwent CMR. LGE was quantified by the full width/half maximum method. The primary endpoint was all-cause mortality. LGE could be adequately assessed in 236 patients, median age was 61 years and median duration of heart failure was 14 months; there were 108 patients (46%) randomized to ICD. Median follow-up time was 5.3 years. Median left ventricular ejection fraction on CMR was 35%. In all, 50 patients died. LGE was present in 113 patients (48%). The presence of LGE was an independent predictor of all-cause mortality (HR 1.82; 95% CI 1.002-3.29; P = .049) after adjusting for known cardiovascular risk factors. ICD implantation did not impact all-cause mortality, for either patients with LGE (HR 1.18; 95% CI 0.59-2.38; P = .63), or for patients without LGE (HR 1.00; 95% CI 0.39-2.53; P = .99), (P for interaction =0.79). CONCLUSION: In patients with non-ischemic systolic heart failure, LGE predicted all-cause mortality. However, in this cohort, LGE did not identify a group of patients who survived longer by receiving an ICD. CI - Copyright (c) 2019 Elsevier Inc. All rights reserved. FAU - Elming, Marie Bayer AU - Elming MB AD - Department of Cardiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. Electronic address: marie.bayer.elming@regionh.dk. FAU - Hammer-Hansen, Sophia AU - Hammer-Hansen S AD - Department of Cardiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. FAU - Voges, Inga AU - Voges I AD - Department of Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, UK. FAU - Nyktari, Eva AU - Nyktari E AD - Department of Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, UK. FAU - Raja, Anna Axelsson AU - Raja AA AD - Department of Cardiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. FAU - Svendsen, Jesper Hastrup AU - Svendsen JH AD - Department of Cardiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. FAU - Pehrson, Steen AU - Pehrson S AD - Department of Cardiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. FAU - Signorovitch, James AU - Signorovitch J AD - Analysis Group Inc., Boston, MA, USA. FAU - Kober, Lars AU - Kober L AD - Department of Cardiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. FAU - Prasad, Sanjay K AU - Prasad SK AD - Department of Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, UK. FAU - Thune, Jens Jakob AU - Thune JJ AD - Department of Cardiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; Department of Cardiology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark. LA - eng GR - BHF_/British Heart Foundation/United Kingdom PT - Journal Article PT - Observational Study PT - Research Support, Non-U.S. Gov't DEP - 20191224 PL - United States TA - Am Heart J JT - American heart journal JID - 0370465 SB - IM CIN - Am Heart J. 2020 Mar;221:177-179. PMID: 31937405 MH - Aged MH - Death, Sudden, Cardiac/*prevention & control MH - *Defibrillators, Implantable MH - Denmark MH - Female MH - Fibrosis MH - Heart/*diagnostic imaging MH - Heart Failure, Systolic/*therapy MH - Humans MH - Magnetic Resonance Imaging MH - Magnetic Resonance Imaging, Cine MH - Male MH - Middle Aged MH - Mortality MH - Myocardium/*pathology MH - Risk Assessment EDAT- 2020/01/21 06:00 MHDA- 2020/04/29 06:00 CRDT- 2020/01/21 06:00 PHST- 2018/11/22 00:00 [received] PHST- 2019/10/30 00:00 [accepted] PHST- 2020/01/21 06:00 [pubmed] PHST- 2020/04/29 06:00 [medline] PHST- 2020/01/21 06:00 [entrez] AID - S0002-8703(19)30351-5 [pii] AID - 10.1016/j.ahj.2019.10.020 [doi] PST - ppublish SO - Am Heart J. 2020 Mar;221:165-176. doi: 10.1016/j.ahj.2019.10.020. Epub 2019 Dec 24.